Yes — genetic testing can guide hormone replacement, but "guide" means something more precise than "predict" or "prescribe." The Precision Peptide Genetic Test maps six Reproductive Health insights across 14 pathways, 49 peptides, and 150+ genetic insights that give providers and patients a defined biological starting point before any hormone support protocol begins.

In the Precision Peptide Genetic Test, the Reproductive Health pathway delivers 6 insights across the genes governing estrogen Phase 1 metabolism, Phase 2 clearance, methylation supply, and receptor sensitivity. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 variants map women's estrogen biology as a connected system — not a checklist of isolated traits.

HRT works differently for every woman because the biological systems that process estrogen are individually variable — and genetics is the layer that explains those differences most precisely. The Precision Peptide Genetic Test maps six variables across 14 pathways, 49 peptides, and 150+ genetic insights that determine how your body handles any hormone support protocol.

Multiple genes shape estrogen levels in women — from production through metabolism to clearance and receptor response. The Precision Peptide Genetic Test analyzes the key variants across 14 pathways, 49 peptides, and 150+ genetic insights, giving providers the genetic picture that estradiol blood tests alone cannot deliver.

The Precision Peptide Genetic Test maps the genetic variables that shape how you experience the menopause transition — from vasomotor symptom intensity to bone density trajectory to mood changes. Part of 14 pathways, 49 peptides, and 150+ genetic insights, your Reproductive Health panel explains why menopause feels profoundly different from one woman to the next.

Two women begin the same hormone support protocol on the same day. Weeks later, one feels significantly better — symptoms eased, energy restored. The other notices little change or unwanted effects. The Precision Peptide Genetic Test maps six biological variables across 14 pathways and 150+ genetic insights that explain this gap — not chance, but genetics.

The Precision Peptide Genetic Test analyzes ESR1 and ESR2 — the two estrogen receptor genes that determine how sensitively your tissues respond to circulating estrogen. Part of 14 pathways, 49 peptides, and 150+ genetic insights, your estrogen receptor variants explain why the same estradiol level produces very different biological effects in different women.

The Precision Peptide Genetic Test analyzes 6 Reproductive Health insights covering women's hormone pathways — COMT, CYP1A1, CYP1B1, MTHFR, ESR1, and Phase 2 detox genes — within a panel of 14 pathways, 49 peptides, and 150+ genetic insights. This pillar guide breaks down how you produce, clear, and respond to estrogen, and why clearance genetics matter as much as production.

In the Precision Peptide Genetic Test, the Reproductive Health pathway delivers 6 insights across genes governing testosterone bioavailability, estrogen conversion, androgen receptor sensitivity, DHT production, and HPTA axis function. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 insights map male hormone balance as a connected genetic system.

Genetics shapes estrogen in men through four pathways: how much testosterone converts to estradiol (CYP19A1), how efficiently it clears (COMT, MTHFR), how sensitively tissues respond (ESR1), and how much substrate is available (SHBG, SRD5A2). The Precision Peptide Genetic Test maps all these variables across 14 pathways and 150+ genetic insights.